FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/038889 [Registered on: 23/12/2021] Trial Registered Prospectively
Last Modified On: 08/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study to see the effect of some Ayurvedic formulation in the treatment of far sightedness. 
Scientific Title of Study   RANDOMIZED CONTROLLED CLINICAL TRIAL ON COMBINATION OF BHASKAR GHRITA NASYA AND SAPTAMRITA LAUHA IN MANAGEMENT OF PRATHAMA-DWITIYA PATALGATA TIMIR w.r.t HYPERMETROPIA 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd Sayali Sahas Patil 
Designation  MS Scholar Shalakyatantra (Ayurved) 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Department of Shalakyatantra, MAMs Sumatibhai Shah Ayurved College, Hadapsar, Pune
Pune
MAHARASHTRA
411028
India 
Phone  8097480795  
Fax    
Email  sayalipatil661@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR PRAVIN M BHAT 
Designation  Associate Professor 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Department of Shalakyatantra, MAMs Sumatibhai Shah Ayurved College, Hadapsar, Pune
Pune
MAHARASHTRA
411028
India 
Phone  09860233173  
Fax    
Email  vdpravin82@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR PRAVIN M BHAT 
Designation  Associate Professor 
Affiliation  Sumatibhai Shah Ayurved Mahavidyalaya 
Address  OPD no. 09, Department of Shalakyatantra, Sane Guruji Arogya Kendra, Malwadi road, Hadapsar, Pune
Department of Shalakyatantra, MAMs Sumatibhai Shah Ayurved College, Hadapsar, Pune

MAHARASHTRA
411028
India 
Phone  09860233173  
Fax    
Email  vdpravin82@gmail.com  
 
Source of Monetary or Material Support  
Department of Shalakyatantra, Sane Guruji Arogya Tantra, Malwadi road, Hadapsar, Pune. 
 
Primary Sponsor  
Name  Sane Guruji Arogya Kendra 
Address  Sane Guruji Arogya, Malwadi road, Hadapsar, Pune. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Vd Sayali Sahas Patil  Sane Guruji Arogya Kendra,Malwadi road, Hadapsar, Pune-411028  Opd no 9, Department of Shalakyatantra
Pune
MAHARASHTRA 
08097480795

sayalipatil661@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H520||Hypermetropia. Ayurveda Condition: TIMIRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Bhaskar Ghrita, Reference: Vangasen Samhita 36/414, Route: Nasal, Dosage Form: Ghrita, Dose: 2(drops), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 21 Days, Reference: No, Route: -, Dosage Form: Ghrita, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: Saptamrita Lauha, Reference: Bhaishajya Ratnavali 64/247, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: hs, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(4) Medicine Name: 21 Days, Reference: Yes, Route: Goghrita, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Comparator ArmDrugClassical(1) Medicine Name: Saptamrita Lauha, Reference: Bhaishajya Ratnavali 64/247, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: hs, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 21 Days, Reference: Yes, Route: Goghrita, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients having symptoms of Prathama Dwitiya Patalgata Timir will be included.
2. Patients who have ≤ +5 D in both the eyes
3. The patient age from 18 years to 60 years of age
4. Patient having vision of 6/9 or less i.e., 6/12, 6/18,6/24, 6/36, 6/60.
5. Patient yogya for Nasya Karma.
6. Patient of either gender will be included in the study. 
 
ExclusionCriteria 
Details  1. Patients having symptoms of Tritiya and Chaturtha Patalgata Timir will be excluded like Kacha and Linganasha.
2. Patient suffering from infectious disease e.g.-viral, bacterial or fungal conjunctivitis, blepharitis and trachoma.
3. Patient having known case of Hypertension, HIV, TB, Rheumatic Heart Disease, Bronchial Asthma, Thyroid disorder.
4. Hypermetropia associated with other ocular disease such as cataract, glaucoma, retinal disease, chorioretinitis, iridocyclitis, choroidal disease, vitreal opacity, cornel opacity, corneal ulcer.
5. Congenital, Acquired non physiological hypermetropia like index hyermetropia, pseudophakic hypermetropia.
6. Refractive errors like astigmatism, myopia, presbyopia and other ocular pathologies will be excluded. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
A clinical study to evaluate efficacy of Bhaskar Ghrita Nasya and Saptamrita Lauha Vati in Prathama and Dwitiya Patalgata Timir w.r.t Hypermetropia. Parameter of efficacy will be visual acuity before and after treatment  Follow up will betaken on 1st, 11th and 21st day. Parameter of efficacy will be visual acuity before and after treatment 
 
Secondary Outcome  
Outcome  TimePoints 
A comparison between efficacy of Bhaskar Ghrita Nasya with Saptamrita Lauha and Saptamrita Lauha alone in Prathama and Dwitiya Patalgata Timir w.r.t Hypermetropia  Total duration of the study will 18 months. 
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "56"
Final Enrollment numbers achieved (India)="56" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/03/2022 
Date of Study Completion (India) 21/12/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
1. The progress of the disease Timira has mentioned in terms of involvement of successive Patalas (layers of eyeball). When the vitiated Doshas invades first Patala, the patient complains of difficulty in distance vision and if not treated it shifts to next patala. 2. Visual disturbance is represented as one of the most complex problem in the field of ophthalmology and it has a great interest ever since the dawn of human life[5]. 3. Hypermetropia is that form of refractive error in which parallel rays of light are bought to a focus some distance behind the sentient layer of the retina when the eye is at rest, the image formed here is therefore made up of circles of diffusion of considerable size, and is consequently blurred [6]. 4. Small amount of hypermetropia in young patients up to +0.50 D for distant is usually corrected by their accommodation, without any defects in vision .If the hypermetropia is high i.e., above +1D there will be defective vision for both distance and near. 5. People may also experience accommodative dysfunction, binocular dysfunction, strabismus and amblyopia. In modern science use of spectacles, contact lenses, laser in situ, keratomiesis, refractive keratometry is been advised. But these all have some limitations. These doesn’t prevent the pathology of refractive error so the blurring of vision continues .Surgeries are costly for everyone and at the same time this operations have some complications.
Bhaskar Ghrita Nasya is an easy and affordable procedure, and also it prevents pathology of Timir, whereas Saptamrita Lauha is best drug to prevent the pathology of Timir. Dravyas included in Bhaskar Ghrita yoga are Yastimadhu, Draksha, Mishri (Khanda),Pippali. Acharya Vangsena has described Bhaskar Ghrita which is selected for study .Dravyas included in Saptamrita Lauha are Yastimadhu, Amalaki, Bibtaki, Haritiki and Lauha Bhasma. In Bhaishajya Ratnavali Saptamrita Lauha has been described in chapter 64 Netra Roga. Purpose of study is to find out solution for Prathama and Dwitiya Patalgata Timir.
 
Close